US Patent 11839654 Combination therapy
Patent 11839654 was granted and assigned to Eli Lilly and Company on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+42 properties)
Article (+274 characters)
US Patent 11839654 Combination therapy
Article
Patent abstract
The present invention provides a method of treating a tau-mediated cognitive or neurodegenerative disease, comprising administering to a patient in need of such treatment an effective amount of an anti-Tau antibody and an effective amount of an OGA inhibitor.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Hugh Nuthall0
Mansuo Lu Hayashi0
Michael Carl Irizarry0
Date of Patent
December 12, 2023
0Patent Application Number
171416670
Date Filed
January 5, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11839654 Combination therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.